bioAffinity Technologies, Inc.
BIAF
$0.83
-$0.01-1.23%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -36.47% | -5.75% | -152.45% | -92.43% | -35.61% |
| Total Depreciation and Amortization | -25.94% | -19.47% | -25.05% | -25.08% | 3.34% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -95.62% | -71.76% | 1,415.67% | 345.28% | 15.12% |
| Change in Net Operating Assets | -48.92% | -56.97% | -686.78% | -81.58% | 165.74% |
| Cash from Operations | -96.56% | -52.61% | -45.11% | -72.75% | 30.02% |
| Capital Expenditure | 88.78% | -- | 138.30% | 52.65% | -22.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 88.78% | -- | 138.30% | 52.65% | -22.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 14.87% | -17.25% | 147.36% | -84.73% | -56.93% |
| Issuance of Common Stock | -- | -33.09% | 325.15% | -- | -54.51% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 25.84% | -80.65% | -- | -- |
| Cash from Financing | -111.48% | -33.85% | 458.16% | 3,413.72% | -48.89% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -407.33% | -449.70% | 15,461.07% | 121.68% | -79.32% |